AMA CPT® Assistant - 2005 Issue 7 (July)
Genetic Modifiers (July 2005)
July 2005 pages 1-8 Genetic Modifiers CPT 2005 features a new appendix that lists numeric-alpha genetic modifiers. These modifiers are appended to the molecular diagnostics codes 83890-83912 when molecular diagnostic procedures are performed to test for infectious disease, oncology, hematology, neurology, or inherited disorders to specify the probe type or condition tested. The new genetic modifiers may also be appended to the cytogenetic studies codes 88245-88291 when molecular diagnostic procedures are performed to test for oncologic or inherited disorders to specify the probe type or condition tested. Why New Modifiers? Typically, new CPT codes are established to describe a...
Subscribe or sign in to view the full article.
Article Overview
This article covers the July 2005 CPT genetic modifier update and how the modifier framework was intended to support reporting of molecular diagnostic and cytogenetic testing. It is relevant to laboratory coders, billing teams, compliance staff, and payers who work with genetics-related CPT reporting. The article provides background on why the modifiers were introduced, the general organization of the modifier set, selected CPT code groups associated with the modifiers, clinical illustrations, and a glossary of genetics terms.
Why This Topic Matters
Genetic testing reporting can involve multiple related procedures and highly specific test characteristics. This article matters because it explains the structure of the CPT modifier approach used to capture that specificity in genetics-related laboratory claims and documentation.
Article Sections
-
July 2005 pages 1-8
Introductory material for the July 2005 article and its scope within CPT Assistant.
-
Why New Modifiers?
Background on the need for a modifier-based approach in genetics-related laboratory reporting and the broader context for CPT code structure.
-
Reporting Solution: Genetic Modifiers
Overview of the modifier framework and its intended role in supporting more specific genetic test reporting and claim processing.
-
How to Use CPT Genetic Modifiers
General explanation of the modifier system layout, how the framework is organized, and the types of CPT code families it was designed to accompany.
-
Clinical Example 1
A worked laboratory scenario illustrating use of the modifier framework in a hereditary thrombosis-related genetic testing context.
-
Rationale
Discussion accompanying the first clinical example that explains the reporting approach in that scenario.
-
Clinical Example 2
A second laboratory scenario involving hereditary cancer-related genetic testing and the associated reporting framework.
-
Rationale
Discussion accompanying the second clinical example and the related reporting approach.
-
Table 1
A reference list of CPT laboratory codes associated with the genetic modifier article and the related code families.
-
Table 2
The modifier reference table organized by broad disease categories and gene or mutation groupings.
-
Glossary
Definitions of core genetics and cytogenetics terminology used in the article.
What You Will Learn
- The purpose and structure of the 2005 CPT genetic modifier update
- How the modifier framework is organized at a high level
- Which broad CPT laboratory code families are associated with the modifier article
- How the article uses clinical scenarios to illustrate genetic modifier reporting
- Basic genetics terminology referenced in the article
Who Should Read This
- Medical coders
- Laboratory billing staff
- Compliance professionals
- Revenue cycle teams
- Payers
- Genetics laboratory personnel
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com